Pluri Inc. Payments to Acquire Available-for-sale Securities, Equity
Pluri Inc. (PLUR) reported Payments to Acquire Available-for-sale Securities, Equity of $7.90 million for the 6-month period ending 2013-12-31, per its 10-Q filed 2014-02-05.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesEquity · last filed 2014-02-05
- Pluri Inc. payments to acquire available-for-sale securities, equity for the quarter ending 2013-12-31 was $3.04M, a 218.31% increase year-over-year.
- Pluri Inc. payments to acquire available-for-sale securities, equity for the quarter ending 2013-09-30 was $4.86M, a 289.50% increase year-over-year.
- Pluri Inc. payments to acquire available-for-sale securities, equity for the quarter ending 2013-06-30 was $6.00M, a 275.05% increase year-over-year.
- Pluri Inc. payments to acquire available-for-sale securities, equity for the quarter ending 2013-03-31 was $333.00K, a 94.92% decline year-over-year.
- Pluri Inc. payments to acquire available-for-sale securities, equity for fiscal 2013 was $8.53M, a 4.52% increase from fiscal 2012.
- Pluri Inc. payments to acquire available-for-sale securities, equity for fiscal 2012 was $8.16M.
| Period end | Payments to Acquire Available-for-sale Securities, Equity 3 month | Payments to Acquire Available-for-sale Securities, Equity 6 month | Payments to Acquire Available-for-sale Securities, Equity 6 month as first filed | Payments to Acquire Available-for-sale Securities, Equity 9 month | Payments to Acquire Available-for-sale Securities, Equity 12 month |
|---|---|---|---|---|---|
| 2013-12-31 | $3.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-05 | $7.90M 10-Q · filed 2014-02-05 | $13.90M derived: sum of 3 quarters · filed 2014-02-05 | $14.23M derived: sum of 4 quarters · filed 2014-02-05 | |
| 2013-09-30 | $4.86M 10-Q · filed 2013-11-05 | $10.86M derived: sum of 2 quarters · filed 2013-11-05 | $11.19M derived: sum of 3 quarters · filed 2013-11-05 | $12.15M derived: sum of 4 quarters · filed 2014-02-05 | |
| 2013-06-30 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | $6.33M derived: sum of 2 quarters · filed 2013-09-11 | $7.29M derived: sum of 3 quarters · filed 2014-02-05 | $8.53M 10-K · filed 2013-09-11 | |
| 2013-03-31 | $333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | $1.29M derived: sum of 2 quarters · filed 2014-02-05 | $2.54M 10-Q · filed 2013-05-08 | $4.14M derived: sum of 4 quarters · filed 2014-02-05 | |
| 2012-12-31 | $956.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-02-05 | $2.20M 10-Q · filed 2014-02-05 | $2.20K 10-Q · filed 2013-01-31 | $3.80M derived: sum of 3 quarters · filed 2014-02-05 | $10.36M derived: sum of 4 quarters · filed 2014-02-05 |
| 2012-09-30 | $1.25M 10-Q · filed 2013-11-05 | $2.85M derived: sum of 2 quarters · filed 2013-11-05 | $9.41M derived: sum of 3 quarters · filed 2013-11-05 | $8.90M derived: sum of 4 quarters · filed 2013-11-05 | |
| 2012-06-30 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-11 | $8.16M derived: sum of 2 quarters · filed 2013-09-11 | $7.65M derived: sum of 3 quarters · filed 2013-09-11 | $8.16M 10-K · filed 2013-09-11 | |
| 2012-03-31 | $6.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-05-08 | $6.05M derived: sum of 2 quarters · filed 2013-05-08 | $6.57M 10-Q · filed 2013-05-08 | ||
| 2011-12-31 | -$511.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-01-31 | $4.50K 10-Q · filed 2013-01-31 | $4.50M 10-Q · filed 2012-02-09 | ||
| 2011-09-30 | $516.00K 10-Q · filed 2012-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |